Abstract—
(1) The inhibitor of γ‐aminobutyrate transaminase (GABA‐T), amino‐oxyacetic acid (AOAA), drastically reduced the activity of GABA‐T to 30 per cent of the control value, with a corresponding increase of brain GABA, but had no effect on the activity of glutamate decarboxylase (GAD).
(2) The monoamine oxidase (MAO) inhibitors phenelzine, phenylpropylhydrazine and phenylvalerylhydrazine, lowered GABA‐T activity to 58, 49 and 48 per cent, respectively; this was associated with a marked elevation of brain GABA.
(3) The action of phenelzine and phenylpropylhydrazine in vivo and in vitro could be abolished by pre‐treatment of the tissue with the structurally related MAO inhibitors phenylisopropylhydrazine and trans‐2‐phenylcyclopropylamine. These had no action on the GABA system in vivo, either on the GABA content or on the GABA‐T activity. These latter drugs, however, were unable to influence the effects of AOAA either on GABA or on GABA‐T.
(4) The possible mechanism of action on GABA and the enzyme activities of the GABA system is discussed.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.